Studies in adult patients indicated that MCP-1 plays a role in the pathogenesis of different forms of ILD, including IPF[9,12,13], PAP[11,14], sarcoidosis[12], scleroderma with lung involvement[49] and granulomatous lung diseases[50]. Here, CCL2 is linked to interstitial lung disease.